Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan versus placebo before coronary revascularization cardiac surgery in high-risk patients
2009-011779-65Phase 4Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and mitral regurgitation (MR) comparing Levosimendan with Placebo (2 arms). Primary endpoints: Immediate postoperative mortality, Intermediate mortality and 1 more. Started Apr 2010; status: completed.
02
Drugs
levosimendan
03
Conditions
coronary arteriosclerosismitral regurgitation (MR)
Beyond the preview
Go deeper on 2009-011779-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011779-65.